Advanced in WT1-Related Wilms Tumor Syndromes

Dr. Mohamad E. Allaf

Urology
Johns Hopkins Medicine
Johns Hopkins University
601 N Caroline St, 
Baltimore, MD 
Accepting New Patients

Advanced in WT1-Related Wilms Tumor Syndromes
Johns Hopkins Medicine
Johns Hopkins University
601 N Caroline St, 
Baltimore, MD 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Mohamad Allaf is an Urologist in Baltimore, Maryland. Dr. Allaf is rated as an Advanced provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Renal Oncocytoma, Prostate Cancer, Nephrectomy, and Prostatectomy. Dr. Allaf is currently accepting new patients.

His clinical research consists of co-authoring 260 peer reviewed articles and participating in 10 clinical trials. MediFind looks at clinical research from the past 15 years.

Specialties
Urology
Licenses
Urology in MD
Hospital Affiliations
Sibley Memorial Hospital
The Johns Hopkins Hospital
Johns Hopkins Bayview Medical Center
Languages Spoken
English
Arabic
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Capital Blue Cross
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • OTHER MEDICARE PART D
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
HealthPartners
  • POS
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Johns Hopkins Healthcare
  • HMO
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE-MEDICAID PLAN
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 6 Less Insurance Carriers -

Locations

JOHNS HOPKINS UNIVERSITY
601 N Caroline St, Baltimore, MD 21287
Call: 410-955-5080

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.


10 Clinical Trials

A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
A Phase 3 RandOmized Study Comparing PERioperative Nivolumab vs. Observation in Patients With Renal Cell Carcinoma Undergoing Nephrectomy (PROSPER RCC)
Enrollment Status: Active_not_recruiting
Publish Date: July 28, 2025
Intervention Type: Other, Biological, Procedure
Study Drug: Nivolumab
Study Phase: Phase 3
Evaluation of Transperineal Biopsy Under Local Anesthesia, a Novel Approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
Evaluation of Transperineal Biopsy Under Local Anesthesia, a Novel Approach to Decrease Post-Biopsy Infections and Improve Cancer Detection
Enrollment Status: Completed
Publish Date: April 15, 2025
Intervention Type: Procedure, Drug
Study Phase: Not Applicable
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
A Confirmatory, Prospective, Open-label, Multi-centre Phase 3 Study to Evaluate Diagnostic Performance of Zirconium-labelled Girentuximab to Non-invasively Detect ccRCC by PET/CT Imaging in Patients With Indeterminate Renal Masses
Enrollment Status: Completed
Publish Date: May 17, 2024
Intervention Type: Diagnostic test
Study Phase: Phase 3
Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: a Prospective Randomized Controlled Trial (ERECT)
Erythropoietin to Enhance Recovery of Erectile Function in Men Following Radical Prostatectomy: a Prospective Randomized Controlled Trial (ERECT)
Enrollment Status: Completed
Publish Date: April 08, 2021
Intervention Type: Drug
Study Phase: Phase 2
Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy
Augmented BLAdder NecK rEconstruction Trial for Improved Urinary Function After Radical Prostatectomy
Enrollment Status: Terminated
Publish Date: March 17, 2021
Intervention Type: Procedure
Study Phase: Not Applicable
A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)
A Randomized Controlled Trial for PREvention of VENous ThromboEmbolism Following Radical Prostatectomy (PREVENTER Trial)
Enrollment Status: Terminated
Publish Date: August 05, 2020
Intervention Type: Drug
Study Phase: Phase 4
Phase I Study of Neoadjuvant Nivolumab in Patients With Non-metastatic High-risk Clear Cell Renal Cell Carcinoma
Phase I Study of Neoadjuvant Nivolumab in Patients With Non-metastatic High-risk Clear Cell Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: June 12, 2020
Intervention Type: Drug
Study Phase: Phase 1
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Study of PSMA-targeted 18F-DCFPyL PET/CT in the Evaluation of Patients With Renal Cell Carcinoma
Enrollment Status: Completed
Publish Date: April 29, 2020
Intervention Type: Drug, Procedure
Study Phase: Not Applicable
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Study of 99mTc-Sestamibi SPECT/CT Imaging for the Preoperative Diagnosis of Renal Oncocytoma
Enrollment Status: Completed
Publish Date: July 30, 2019
Intervention Type: Other
Study Phase: Not Applicable
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
A Phase 3 Study to Evaluate the Safety and Efficacy of 99mTc-MIP-1404 SPECT/CT Imaging to Detect Clinically Significant Prostate Cancer in Men With Biopsy Proven Low-Grade Prostate Cancer Who Are Candidates for Active Surveillance (proSPECT-AS)
Enrollment Status: Completed
Publish Date: April 10, 2019
Intervention Type: Drug, Diagnostic test
Study Phase: Phase 3
View 9 Less Clinical Trials

260 Total Publications

Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions.
Clinically significant prostate cancer detected by systematic biopsy in patients with MRI lesions.
Journal: BJU international
Published: June 12, 2025
View All 260 Publications
Similar Doctors
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael W. Phelan
Urology | General Surgery
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Michael W. Phelan
Urology | General Surgery

University Of Maryland Surgical Associates PA

419 W Redwood St, Fl 3, 
Baltimore, MD 
 (1.5 miles away)
410-328-5300
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Michael Phelan is an Urologist and a General Surgeon in Baltimore, Maryland. Dr. Phelan is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Renal Cell Carcinoma (RCC), Chromophobe Renal Cell Carcinoma, WT1-Related Wilms Tumor Syndromes, Nephrectomy, and Reconstructive Urology Surgery. Dr. Phelan is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rian J. Dickstein
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Rian J. Dickstein
Urology

Chesapeake Urology Associates LLC

6535 N Charles St, Suite 625, 
Baltimore, MD 
 (6.4 miles away)
410-825-5454
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rian Dickstein is an Urologist in Baltimore, Maryland. Dr. Dickstein is rated as an Elite provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Bladder Cancer, Non-Muscle Invasive Bladder Cancer, Hydronephrosis, Ureteroscopy, and Nephrectomy. Dr. Dickstein is currently accepting new patients.

Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mark S. Shimko
Urology
Distinguished in WT1-Related Wilms Tumor Syndromes
Dr. Mark S. Shimko
Urology

Chesapeake Urology Associates LLC

1838 Greene Tree Rd, Suite 460, 
Baltimore, MD 
 (9.9 miles away)
410-581-8140
Languages Spoken:
English
See accepted insurances
Accepting New Patients

Mark Shimko is an Urologist in Baltimore, Maryland. Dr. Shimko is rated as a Distinguished provider by MediFind in the treatment of WT1-Related Wilms Tumor Syndromes. His top areas of expertise are Prostate Cancer, Familial Prostate Cancer, UPJ Obstruction, Nephrectomy, and Reconstructive Urology Surgery. Dr. Shimko is currently accepting new patients.

VIEW MORE WT1-RELATED WILMS TUMOR SYNDROMES DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Allaf's expertise for a condition
ConditionClose
  • Elite
  • Nephrectomy
    Dr. Allaf is
    Elite
    . Learn about Nephrectomy.
    See more Nephrectomy experts
  • Prostate Cancer
    Dr. Allaf is
    Elite
    . Learn about Prostate Cancer.
    See more Prostate Cancer experts
  • Prostatectomy
    Dr. Allaf is
    Elite
    . Learn about Prostatectomy.
    See more Prostatectomy experts
  • Renal Cell Carcinoma (RCC)
    Dr. Allaf is
    Elite
    . Learn about Renal Cell Carcinoma (RCC).
    See more Renal Cell Carcinoma (RCC) experts
  • Renal Oncocytoma
    Dr. Allaf is
    Elite
    . Learn about Renal Oncocytoma.
    See more Renal Oncocytoma experts
  • Distinguished
  • Familial Prostate Cancer
    Dr. Allaf is
    Distinguished
    . Learn about Familial Prostate Cancer.
    See more Familial Prostate Cancer experts
  • Testicular Cancer
    Dr. Allaf is
    Distinguished
    . Learn about Testicular Cancer.
    See more Testicular Cancer experts
  • Advanced
  • Chromophobe Renal Cell Carcinoma
    Dr. Allaf is
    Advanced
    . Learn about Chromophobe Renal Cell Carcinoma.
    See more Chromophobe Renal Cell Carcinoma experts
  • Clear Cell Sarcoma
    Dr. Allaf is
    Advanced
    . Learn about Clear Cell Sarcoma.
    See more Clear Cell Sarcoma experts
  • Empyema
    Dr. Allaf is
    Advanced
    . Learn about Empyema.
    See more Empyema experts
  • Familial Wilms Tumor 2
    Dr. Allaf is
    Advanced
    . Learn about Familial Wilms Tumor 2.
    See more Familial Wilms Tumor 2 experts
  • Orchiectomy
    Dr. Allaf is
    Advanced
    . Learn about Orchiectomy.
    See more Orchiectomy experts
  • Thrombectomy
    Dr. Allaf is
    Advanced
    . Learn about Thrombectomy.
    See more Thrombectomy experts
View All 10 Advanced Conditions
  • Experienced
  • Bladder Cancer
    Dr. Allaf is
    Experienced
    . Learn about Bladder Cancer.
    See more Bladder Cancer experts
  • Chylous Ascites
    Dr. Allaf is
    Experienced
    . Learn about Chylous Ascites.
    See more Chylous Ascites experts
  • Endoscopy
    Dr. Allaf is
    Experienced
    . Learn about Endoscopy.
    See more Endoscopy experts
  • Enlarged Prostate (BPH)
    Dr. Allaf is
    Experienced
    . Learn about Enlarged Prostate (BPH).
    See more Enlarged Prostate (BPH) experts
  • Erectile Dysfunction (ED)
    Dr. Allaf is
    Experienced
    . Learn about Erectile Dysfunction (ED).
    See more Erectile Dysfunction (ED) experts
  • Intussusception in Children
    Dr. Allaf is
    Experienced
    . Learn about Intussusception in Children.
    See more Intussusception in Children experts
View All 15 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2025 All Rights Reserved